AMES, Iowa--(BUSINESS WIRE)--BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH), a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that its Nano eNabler™ molecular printer was called a “disruptive technology” in a recent report by Frost and Sullivan. The report highlighted key advantages over existing technologies for the deposition of biological materials via printing and lithography at ultramicro and nano levels. These capabilities are a critical step in the development and production of new types of miniaturized biosensors for detecting pathogens or screening biomarkers.
